Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PRP Protocol A is a standardized method for obtaining and preparing autologous platelet-rich plasma (PRP) for intra-articular injection. This protocol involves collecting 50 mL of peripheral blood, followed by a double centrifugation process: first for 10 minutes at 1200 rpm, and then the separated plasma is centrifuged again for 5 minutes at 1200 rpm. The resulting 5 mL of concentrated PRP is intended for therapeutic use, primarily in the conservative treatment of mild to moderate knee osteoarthritis. The therapeutic effect of PRP is attributed to the elevated concentration of platelets, which release various growth factors and cytokines that promote tissue repair, reduce inflammation, and improve joint function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PRP Protocol A.